IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
13 hedge funds and large institutions have $172K invested in Immune Pharmaceuticals Inc. in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$47K | |
| 2 | +$26K | |
| 3 | +$16.9K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$1.86K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$911 |
Top Sellers
| 1 | -$10K | |
| 2 | -$8K | |
| 3 | -$6K | |
| 4 |
Bank of New York Mellon
New York
|
-$5K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$1K |